ZolaCos CP 3.6/50 (goserelin (&) bicalutamide)

goserelin 3.6 mg implant [1] (&) bicalutamide 50 mg tablet [28], 1 pack · IMPLANTATION_ORAL · PBS code 9064C

RESTRICTED

What it costs

AU$358.96 PBS-determined price per 1 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

• First listed on the PBS: 2007-03-01.
• Repeats: 5.
• PBS program: GE.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Carcinoma of the prostate

The condition must be metastatic (stage D); AND

Patient must require a combination of an antiandrogen and a GnRH (LH-RH) agonist; AND

Must be treated by a medical practitioner; or

Must be treated by a nurse practitioner where both of the following are occurring: (i) patient care is being shared with a medical practitioner, (ii) the prescription continues existing therapy with this medicine.

Sponsor: AstraZeneca Pty Ltd ABN 54 009 682 311

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.